LabCompass
Established · publishing since 1997Rising activity

Publications

30

Citations

2,893

Est. group size

Recurring co-author estimate

Active years

29

Publishing since 1997

Research summary
AI-generated

Yue Xu's research centers on kidney biology and drug discovery, particularly the development of novel diuretic compounds that target urea transporters as an alternative treatment approach for conditions like hyponatremia (low blood sodium) and acute kidney injury. The work spans preclinical pharmacology (drug design, pharmacokinetics, animal models), stem cell-based therapies for kidney injury, and studies of kidney disease mechanisms such as polycystic kidney disease and prostate cancer, with some publications also touching on unrelated topics like environmental impact assessment and public health.

Urea transporter-targeted diuretic drug discoveryAcute kidney injury and mesenchymal stem cell therapyPolycystic kidney disease mechanismsPharmacokinetics and drug development for renal diseaseKidney and urogenital cancer biology

Publication output was low and steady (about 1 per year) from 2017-2020, then increased notably from 2021 onward, reaching its highest levels in 2024 and 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.8/year recently
2017: 1 publication172018: 1 publication182019: 1 publication192020: 1 publication202021: 4 publications212022: 2 publications222023: 1 publication232024: 5 publications242025: 6 publications62526
Recent publications
Publishes in
  • Acta Pharmacologica Sinica×2
  • Biomedicines×2
  • Human Cell×1
  • Acta Pharmaceutica Sinica B×1
  • Journal of the American Society of Nephrology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile